358 related articles for article (PubMed ID: 7501940)
1. [Curative antifungal treatment of invasive pulmonary aspergillosis].
Andrès E; Courouau F; Kurtz JE; Limacher JM; Quoix E
Rev Pneumol Clin; 1995; 51(4):228-31. PubMed ID: 7501940
[TBL] [Abstract][Full Text] [Related]
2. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of pulmonary aspergilloma. Clinical review].
Martínez J; Márquez M; Sola O; Arés J; Grarau J
Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):413-5. PubMed ID: 11153205
[No Abstract] [Full Text] [Related]
4. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
Sambatakou H; Dupont B; Lode H; Denning DW
Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin: new preparation. A last resort in invasive aspergillosis.
Prescrire Int; 2002 Oct; 11(61):142-3. PubMed ID: 12378745
[TBL] [Abstract][Full Text] [Related]
6. [Choice and use of antifungal drugs].
Dupont B
Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
8. Anti-fungal chemotherapy for symptomatic pulmonary aspergilloma.
Kawana A; Yamauchi Y; Kudo K
Jpn J Infect Dis; 2000 Feb; 53(1):29-30. PubMed ID: 10777860
[No Abstract] [Full Text] [Related]
9. [Medical therapy of pleuro-pulmonary aspergillosis].
Guérin JC; Woehrle R; Kalb JC
J Med Lyon; 1972 May; 53(228):621-2 passim. PubMed ID: 4538887
[No Abstract] [Full Text] [Related]
10. Quiz page. Invasive pulmonary aspergillosis presenting with a pulmonary nodule, pneumomediastinum, pneumothorax, and pneumopericardium.
Sengul S; Keven K; Kutlay S; Ergun I; Azap A; Erbay B
Am J Kidney Dis; 2004 Oct; 44(4):A47, E47-9. PubMed ID: 15384032
[No Abstract] [Full Text] [Related]
11. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
12. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
13. Changes in the natural history of invasive pulmonary aspergillosis in neutropenic leukemic patients.
Ruchlemer R; Yinnon AM; Hershko C
Isr J Med Sci; 1996 Nov; 32(11):1089-92. PubMed ID: 8960078
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
15. [Palliative percutaneous treatment under ultrasonographic control of inoperable pulmonary aspergilloma: Galenic analysis].
Meges B; Segonds M; Garo A; Ane M; Giron J; Carles P
Rev Mal Respir; 1996 Dec; 13(6):614-5. PubMed ID: 9036512
[No Abstract] [Full Text] [Related]
16. Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.
Stevens DA; Kan VL; Judson MA; Morrison VA; Dummer S; Denning DW; Bennett JE; Walsh TJ; Patterson TF; Pankey GA
Clin Infect Dis; 2000 Apr; 30(4):696-709. PubMed ID: 10770732
[TBL] [Abstract][Full Text] [Related]
17. Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases.
Dornbusch HJ; Urban CE; Pinter H; Ginter G; Fotter R; Becker H; Miorini T; Berghold C
Pediatr Hematol Oncol; 1995; 12(6):577-86. PubMed ID: 8589003
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
19. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
20. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]